Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

OtherReview Articles

Update on Brain Tumor Imaging: From Anatomy to Physiology

S. Cha
American Journal of Neuroradiology March 2006, 27 (3) 475-487;

References

  1. ↵
    Nolte J. Gross anatomy and general organization of the central nervous system. In: The human brain: an introduction to its functional anatomy. 4th ed. St Louis: Mosby;1999 :51–75
  2. ↵
    Daumas-Duport C, Beuvon F, Varlet P, et al. [Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol 2000;20:413–28
    PubMedWeb of Science
  3. ↵
    Bulakbasi N, Guvenc I, Onguru O, et al. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004;28:735–46
    CrossRefPubMed
  4. Kitis O, Altay H, Calli C, et al. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55:393–400
    CrossRefPubMed
  5. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88
    Abstract/FREE Full Text
  6. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60
    CrossRefPubMedWeb of Science
  7. ↵
    Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83
    CrossRefPubMedWeb of Science
  8. ↵
    Filippi CG, Edgar MA, Ulug AM, et al. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001;22:65–72
    Abstract/FREE Full Text
  9. ↵
    Smith JS, Cha S, Mayo MC, et al. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 2005;103:428–38
    CrossRefPubMedWeb of Science
  10. ↵
    Klatzo I. Presidental address: neuropathological aspects of brain edema. J Neuropathol Exp Neurol 1967;26:1–14
    PubMedWeb of Science
  11. ↵
    Eis M, Els T, Hoehn-Berlage M, et al. Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir Suppl (Wien) 1994;60:344–46
    PubMed
  12. ↵
    Pauleit D, Langen KJ, Floeth F, et al. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? J Magn Reson Imaging 2004;20:758–64
    CrossRefPubMedWeb of Science
  13. ↵
    Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24:937–41
    Abstract/FREE Full Text
  14. ↵
    Jellison BJ, Field AS, Medow J, et al. Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am J Neuroradiol 2004;25:356–69
    FREE Full Text
  15. ↵
    Lu S, Ahn D, Johnson G, et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004;232:221–28
    CrossRefPubMedWeb of Science
  16. ↵
    Roberts TP, Liu F, Kassner A, et al. Fiber density index correlates with reduced fractional anisotropy in white matter of patients with glioblastoma. AJNR Am J Neuroradiol 2005;26:2183–86
    Abstract/FREE Full Text
  17. ↵
    DaSilva AF, Tuch DS, Wiegell MR, et al. A primer on diffusion tensor imaging of anatomical substructures. Neurosurg Focus 2003;15:E4
    PubMed
  18. ↵
    Beaulieu C, Allen PS. Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994;31:394–400
    CrossRefPubMedWeb of Science
  19. ↵
    Yu CS, Li KC, Xuan Y, et al. Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment. Eur J Radiol 2005;56:197–204
    CrossRefPubMed
  20. ↵
    Astrakas LG, Zurakowski D, Tzika AA, et al. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 2004;10:8220–28
    Abstract/FREE Full Text
  21. Fountas KN, Kapsalaki EZ, Vogel RL, et al. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004;82:90–97
    CrossRefPubMed
  22. Huang Y, Lisboa PJ, El-Deredy W. Tumour grading from magnetic resonance spectroscopy: a comparison of feature extraction with variable selection. Stat Med 2003;22:147–64
    PubMed
  23. ↵
    Lukas L, Devos A, Suykens JA, et al. Brain tumor classification based on long echo proton MRS signals. Artif Intell Med 2004;31:73–89
    CrossRefPubMed
  24. ↵
    Herminghaus S, Dierks T, Pilatus U, et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 2003;98:74–81
    PubMed
  25. ↵
    Ando K, Ishikura R, Nagami Y, et al. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions]. Nippon Igaku Hoshasen Gakkai Zasshi 2004;64:121–26
    PubMed
  26. Plotkin M, Eisenacher J, Bruhn H, et al. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 2004;70:49–58
    CrossRefPubMed
  27. ↵
    Traber F, Block W, Flacke S, et al. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence]. Rofo 2002;174:33–42
    CrossRefPubMed
  28. ↵
    Burger P. Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986;13:16–20
    PubMed
  29. ↵
    Chan AS, Leung SY, Wong MP, et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 1998;22:816–26
    CrossRefPubMedWeb of Science
  30. Plate KH, Mennel HD. Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 1995;47:89–94
    CrossRefPubMedWeb of Science
  31. Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71–103
    CrossRefPubMedWeb of Science
  32. ↵
    Zagzag D, Friedlander DR, Margolis B, et al. Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 2000;33:49–55
    CrossRefPubMedWeb of Science
  33. ↵
    Allen N. Oxidative metabolism of brain tumors. Prog Exp Tumor Res 1972;17:192–209
    PubMed
  34. ↵
    Remy C, Fouilhe N, Barba I, et al. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 1997;57:407–14
    Abstract/FREE Full Text
  35. ↵
    Kuesel AC, Sutherland GR, Halliday W, et al. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR in biomedicine 1994;7:149–55
    PubMed
  36. ↵
    Kaminogo M, Ishimaru H, Morikawa M, et al. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 2001;43:353–63
    CrossRefPubMedWeb of Science
  37. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449–58
    CrossRefPubMedWeb of Science
  38. ↵
    Cheng LL, Chang I-W, Louis DN, et al. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825–32
    Abstract/FREE Full Text
  39. ↵
    Star-Lack J, Spielman D, Adalsteinsson E, et al. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson 1998;133:243–54
    CrossRefPubMedWeb of Science
  40. ↵
    Li X, Vigneron DB, Cha S, et al. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 2005;26:760–69
    Abstract/FREE Full Text
  41. ↵
    Hoxworth JM, Cha S, Butowski N, et al. Lactate-edited MRSI: Increased lactate in high grade gliomas prior to radiotherapy predicts treatment failure. In: Abstracts from the Society for Neuro-oncology Ninth Annual Meeting, Toronto 2004 :360
  42. ↵
    Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995;15:339–47
    CrossRefPubMedWeb of Science
  43. Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 1997;32:253–65
    CrossRefPubMed
  44. ↵
    Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000;88:2606–18
    CrossRefPubMedWeb of Science
  45. ↵
    Puduvalli VK, Sawaya R. Antiangiogenesis: therapeutic strategies and clinical implications for brain tumors. J Neurooncol 2000;50:189–200
    CrossRefPubMed
  46. ↵
    Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1962;10:393–407
    FREE Full Text
  47. ↵
    Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Res Med 1990;14:249–65
    PubMedWeb of Science
  48. ↵
    Weisskoff R, Belliveau J, Kwong K, et al. Functional MR imaging of capillary hemodynamics. In: Potchen E, ed. Magnetic resonance angiography: concepts and applications. St Louis: Mosby;1993 :473–84
  49. ↵
    Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357–66
    Abstract/FREE Full Text
  50. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29
    CrossRefPubMedWeb of Science
  51. Chan A, Nelson S. Simplified gamma variate fitting of perfusion curves. IEEE Int Symp Biomed Imaging 2004;1067–70
  52. Chan A, Pirzkall A, Nelson S. Analysis of serial changes in perfusion parameters for patients with recurrent high grade gliomas being treated with radiosurgery. In: Intl Soc Magn Reson Med. Kyoto, Japan,2004
  53. Jackson A, Kassner A, Zhu XP, et al. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging 2001;14:510–16
    CrossRefPubMed
  54. Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14
    Abstract/FREE Full Text
  55. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98
    CrossRefPubMedWeb of Science
  56. ↵
    Weisskoff RM, Boxerman JL, Sorensen AG, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: International Society for Magnetic Resonance in Medicine. San Francisco,1994;279
  57. ↵
    Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 2005;26:1446–54
    Abstract/FREE Full Text
  58. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51
    PubMedWeb of Science
  59. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98
    CrossRefPubMedWeb of Science
  60. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214–21
    Abstract/FREE Full Text
  61. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86
    CrossRefPubMedWeb of Science
  62. ↵
    Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26:266–73
    Abstract/FREE Full Text
  63. ↵
    Cha S, Martin A, Weber O, et al. Intravenous and intra-arterial bolus tracking perfusion MR imaging of meningiomas before and after embolization [abstract]. In: Proceedings of the 43rd Annual Meeting of the American Society of Neuroradiology, Toronto, 2005; Neuro News, presentation number NN3
  64. ↵
    Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989;63:939–47
    CrossRefPubMedWeb of Science
  65. ↵
    Posner JB. Management of brain metastases. Rev Neurol 1992;148:477–87
    PubMed
  66. ↵
    Long DM. Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 1979;51:53–58
    PubMedWeb of Science
  67. ↵
    Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–21
    PubMedWeb of Science
  68. ↵
    Essig M, Waschkies M, Wenz F, et al. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology 2003;228:193–99
    PubMed
  69. ↵
    Schwartz RB, Carvalho PA, Alexander ED, et al. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. AJNR Am J Neuroradiol 1991;12:1187–92
    Abstract/FREE Full Text
  70. ↵
    Morgenstern LB, Frankowski RF. Brain tumor masquerading as stroke. J Neurooncol 1999;44:47–52
    CrossRefPubMed
  71. ↵
    Zagzag D, Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology: clues to a correct pathological diagnosis. Am J Surg Pathol 1993;17:537–45
    CrossRefPubMedWeb of Science
  72. ↵
    Ritter JH, Humphrey PA, Wick MR. Malignant neoplasms capable of simulating inflammatory (myofibroblastic) pseudotumors and tumefactive fibroinflammatory lesions: pseudopseudotumors. Semin Diagn Pathol 1998;15:111–32
    PubMedWeb of Science
  73. ↵
    Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–16
    CrossRefPubMedWeb of Science
  74. Stewart PA, Hayakawa K, Farrell CL, et al. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue: evidence for a blood-brain barrier defect. J Neurosurg 1987;67:697–705
    PubMedWeb of Science
  75. Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with double-echo dynamic MR imaging: theory and clinical application. Radiology 2000;214:912–17
    PubMed
  76. ↵
    Yang S, Law M, Zagzag D, et al. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003;24:1554–59
    Abstract/FREE Full Text
  77. ↵
    Roberts HC, Roberts TP, Brasch RC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–99
    Abstract/FREE Full Text
  78. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55
    Abstract/FREE Full Text
  79. ↵
    Roberts HC, Roberts TP, Ley S, et al. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9(suppl 1):S151–55
  80. ↵
    Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357–67
    CrossRefPubMedWeb of Science
  81. ↵
    Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509–20
    CrossRefPubMedWeb of Science
  82. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254–59
    CrossRefPubMedWeb of Science
  83. ↵
    Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999;10:903–07
    CrossRefPubMedWeb of Science
  84. ↵
    Tofts PS, Barker GJ, Filippi M, et al. An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of MRI brain lesion volume estimation schemes in multiple sclerosis. Magn Reson Imaging 1997;15:183–92
    CrossRefPubMedWeb of Science
  85. ↵
    Roberts HC, Roberts TP, Bollen AW, et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001;8:384–91
    CrossRefPubMed
  86. ↵
    George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628–36
    CrossRefPubMedWeb of Science
  87. ↵
    Knopp MV, Giesel FL, Marcos H, et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001;12:301–08
    CrossRefPubMed
  88. ↵
    Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47:601–06
    CrossRefPubMedWeb of Science
  89. ↵
    Patankar TF, Haroon HA, Mills SJ, et al. Is volume transfer coefficient (K[trans]) related to histologic grade in human gliomas? AJNR Am J Neuroradiol 2005;26:2455–65
    Abstract/FREE Full Text
  90. ↵
    Ludemann L, Grieger W, Wurm R, et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001;11:1231–41
    CrossRefPubMed
  91. ↵
    Johnson G, Wetzel SG, Cha S, et al. Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51:961–68
    CrossRefPubMed
  92. ↵
    Leach MO, Brindle KM, Evelhoch JL, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003;76:S87–91
    FREE Full Text
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Update on Brain Tumor Imaging: From Anatomy to Physiology
S. Cha
American Journal of Neuroradiology Mar 2006, 27 (3) 475-487;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

  • No related articles found.

Cited By...

More in this TOC Section

Similar Articles

Advertisement